-
公开(公告)号:US20120270789A1
公开(公告)日:2012-10-25
申请号:US13377497
申请日:2009-06-12
IPC分类号: A61K38/17 , A61P7/04 , C07K14/705
CPC分类号: C12Q1/56 , A61K38/366 , C07K14/7455 , C12Q2521/537 , G01N33/86
摘要: The present invention relates to the use of thrombomodulin analogues for the manufacture of a medicament for the treatment of coagulopathy with hyperfibrinolysis, such as haemophilia disorders. These thrombomodulin analogs exhibit at therapeutically effective dosages an antifibrinolytic effect. Novel protein modifications together with methods for their identification are disclosed.
摘要翻译: 本发明涉及血栓调节蛋白类似物在制备用于治疗血纤维蛋白溶解如血友病障碍的凝血病的药物中的用途。 这些血栓调节蛋白类似物以治疗有效剂量表现出抗纤维蛋白溶解作用。 公开了新的蛋白质修饰及其鉴定方法。
-
公开(公告)号:US20140256640A1
公开(公告)日:2014-09-11
申请号:US14026037
申请日:2013-09-13
IPC分类号: C07K14/745 , C12Q1/56
CPC分类号: C12Q1/56 , A61K38/366 , C07K14/7455 , C12Q2521/537 , G01N33/86
摘要: The present invention relates to the use of thrombomodulin analogues for the manufacture of a medicament for the treatment of coagulopathy with hyperfibrinolysis, such as haemophilia disorders. These thrombomodulin analogs exhibit at therapeutically effective dosages an antifibrinolytic effect. Novel protein modifications together with methods for their identification are disclosed.
摘要翻译: 本发明涉及血栓调节蛋白类似物在制备用于治疗血纤维蛋白溶解如血友病障碍的凝血病的药物中的用途。 这些血栓调节蛋白类似物以治疗有效剂量表现出抗纤维蛋白溶解作用。 公开了新的蛋白质修饰及其鉴定方法。
-